Affordable Access

deepdyve-link
Publisher Website

Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study.

Authors
  • Brett, Jonathan1
  • Daniels, Benjamin1
  • Karanges, Emily A1
  • Buckley, Nicholas A2
  • Schneider, Carl3
  • Nassir, Atheer3
  • McLachlan, Andrew J3, 4
  • Pearson, Sallie-Anne1, 2, 5
  • 1 Medicines Policy Research Unit, Centre for Big Data Research in Health, University of New South Wales, Australia. , (Australia)
  • 2 School of Medicine, The University of Sydney, Sydney, Australia. , (Australia)
  • 3 Faculty of Pharmacy, The University of Sydney, Sydney, Australia. , (Australia)
  • 4 Centre for Education and Research on Ageing, Concord Hospital, Sydney, Australia. , (Australia)
  • 5 Menzies Centre for Health Policy, The University of Sydney, Sydney, Australia. , (Australia)
Type
Published Article
Journal
British Journal of Clinical Pharmacology
Publisher
Wiley (Blackwell Publishing)
Publication Date
Nov 01, 2017
Volume
83
Issue
11
Pages
2581–2588
Identifiers
DOI: 10.1111/bcp.13369
PMID: 28689375
Source
Medline
Keywords
License
Unknown

Abstract

Psychotropic polypharmacy is common, despite limited evidence of risks and benefits. Increases in polypharmacy with multiple prescribers may be due to poor communication with patients and between health care professionals.

Report this publication

Statistics

Seen <100 times